Inherited mutations in DNA repair genes in men with metastatic castration-resistant prostate cancer.

被引：3
|
作者：
Nelson, Peter
Mateo, Joaquin
Beltran, Himisha
De Sarkar, Navonil
Elemento, Olivier
Rubin, Mark A.
Vinson, Jacob N.
Filipenko, Julie
Robinson, Dan R.
Chinnaiyan, Arul M.
Van Allen, Eliezer Mendel
Garofalo, Andrea
Taplin, Mary-Ellen
Garraway, Levi A.
Carreira, Suzanne
Montgomery, Robert B.
Morrissey, Colm
Cheng, Heather H.
De Bono, Johann S.
Pritchard, Colin C.
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[3] Inst Canc Res, Sutton, Surrey, England
[4] Weill Cornell Med Coll, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[6] Univ Michigain Hlth Syst, Ann Arbor, MI USA
[7] Univ Michigan, Ann Arbor, MI 48109 USA
[8] Dana Farber Canc Inst, Boston, MA 02115 USA
[9] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[10] Inst Canc Res, Canc Biomarkers Lab, London, England
[11] Univ Washington Oncol, Seattle, WA USA
[12] Univ Washington, Dept Urol, Seattle, WA 98195 USA
[13] Univ Washington, Seattle, WA 98195 USA
[14] Royal Marsden NHS Fdn Trust, London, England
[15] Inst Canc Res, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5009
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
    Pond, Gregory R.
    Sonpavde, Guru
    de Wit, Ronald
    Eisenberger, Mario A.
    Tannock, Ian F.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2014, 65 (01) : 3 - 6
  • [22] Characterization of PSA at death in patients with metastatic castration-resistant prostate cancer.
    Bikkasani, Krishna
    Qin, Qian
    Lin, Justin
    Galsky, Matt D.
    Liaw, Bobby Chi-Hung
    Oh, William K.
    Tsao, Che-Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [23] Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer
    Armstrong, Andrew J.
    Eisenberger, Mario A.
    Halabi, Susan
    Oudard, Stephane
    Nanus, David M.
    Petrylak, Daniel P.
    Sartor, A. Oliver
    Scher, Howard I.
    EUROPEAN UROLOGY, 2012, 61 (03) : 549 - 559
  • [24] Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer
    Graff, Julie N.
    Gordon, Max J.
    Beer, Tomasz M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 749 - 754
  • [25] Docetaxel in very elderly men with metastatic castration-resistant prostate cancer
    Wong, Hui-Li
    Lok, Sheau Wen
    Wong, Shirley
    Parente, Phillip
    Rosenthal, Mark
    PROSTATE INTERNATIONAL, 2015, 3 (02) : 42 - 46
  • [26] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    Armstrong, A. J.
    George, D. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 108 - 116
  • [27] Identifying enzalutamide resistance mechanisms in men with castration-resistant prostate cancer.
    Alumkal, Joshi J.
    Heiser, Laura
    Beer, Tomasz M.
    Small, Eric Jay
    Baertsch, Robert
    Stuart, Josh
    King, Carly
    Korkola, James
    Cetnar, Jeremy
    Graff, Julie Nicole
    Thomas, George
    Ryan, Christopher W.
    Toschi, Alexandria
    Youngren, Jack
    Tucker, Erin
    Ellers, Kristi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Optimizing the use of docetaxel in men with castration-resistant metastatic prostate cancer
    A J Armstrong
    D J George
    Prostate Cancer and Prostatic Diseases, 2010, 13 : 108 - 116
  • [29] Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Luber, Brandon
    Liang, Chao
    Wang, Hao
    Chen, Yan
    Silberstein, John L.
    Piana, Danilo
    Lai, Zhao
    Chen, Yidong
    Isaacs, William B.
    Luo, Jun
    EUROPEAN UROLOGY, 2018, 74 (02) : 218 - 225
  • [30] Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer
    Maughan, Benjamin L.
    Antonarakis, Emmanuel S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (12) : 1625 - 1632
12345